PSC-CROHNS DISEASE: CHARACTERISATION OF THIS PATIENT GROUP FOR THE FIRST TIME REVEALS A UNIQUE CLINICAL PHENOTYPE

PSC-CROHNS DISEASE: CHARACTERISATION OF THIS PATIENT GROUP FOR THE FIRST TIME REVEALS A UNIQUE CLINICAL PHENOTYPE

書誌詳細
主要な著者:	Halliday, J, Djordjevic, J, Culver, E, Travis, S, Lust, M, Braden, B, Chapman, R
フォーマット:	Conference item
出版事項:	2011

類似資料

A unique clinical phenotype of primary sclerosing cholangitis associated with Crohn's disease.
著者:: Halliday, J, 等
出版事項: (2012)

A unique clinical phenotype of primary sclerosing cholangitis associated with Crohn's disease
著者:: Halliday, J, 等
出版事項: (2012)

Risk for colorectal neoplasia in patients with colonic Crohn's disease and concomitant primary sclerosing cholangitis.
著者:: Braden, B, 等
出版事項: (2012)

Has primary sclerosing cholangitis associated with Crohn's disease a better outcome? Reply
著者:: Halliday, J, 等
出版事項: (2012)

PHENOTYPIC DESCRIPTION OF A LARGE COHORT OF PSC PATIENTS IN THE UK
著者:: Srivastava, B, 等
出版事項: (2011)

Impact of interobserver disagreement on phenotype-genotype associations in Crohn's disease.
著者:: Oefferlbauer-Ernst, A, 等
出版事項: (2007)

Recurrent posterior scleritis and orbital myositis as extra-intestinal manifestations of Crohn's disease: Case report and systematic literature review.
著者:: Culver, E, 等
出版事項: (2008)

Evidence for separate disease phenotypes in intestinal Crohn's disease.
著者:: Borley, N, 等
出版事項: (2002)

Choline Ameliorates Disease Phenotypes in Human iPSC Models of Rett Syndrome
著者:: Chin, Eunice W. M., 等
出版事項: (2016)

Concomitant primary sclerosing cholangitis does not increase the risk for colorectal dysplasia in patients with colonic Crohn's disease
著者:: Braden, B, 等
出版事項: (2008)

INAPPROPRIATE EXPRESSION OF BLOOD-GROUP ANTIGENS ON THE BILIARY EPITHELIUM IN PRIMARY SCLEROSING CHOLANGITIS (PSC)
著者:: Bloom, S, 等
出版事項: (1990)

The colon and PSC: new liver, new danger?
著者:: Chapman, R
出版事項: (1998)

Phenotyping C9-ALS/FTD iPSC-derived cortical neurons
著者:: Graf, MS
出版事項: (2023)

IMMUNOGENETIC FACTORS IN THE CLINICAL COURSE OF PRIMARY SCLEROSING CHOLANGITIS (PSC)
著者:: Mehal, W, 等
出版事項: (1993)

Medical management of Crohn's disease.
著者:: Cummings, JR, 等
出版事項: (2008)

Mortality in patients hospitalised with Crohn's disease.
著者:: Siffledeen, J, 等
出版事項: (2012)

Crohn’s disease or Crohn’s diseases?
著者:: Arnott, IDR, 等
出版事項: (2003)

Phenotypic modelling of Crohn's disease severity: a machine learning approach
著者:: Niehaus, K
出版事項: (2016)

Interfering with leukocyte trafficking in Crohn's disease
著者:: Biswas, S, 等
出版事項: (2019)

Wonders of Oud reveals the uniqueness of agarwood
著者:: Shalfarina, Shahriman
出版事項: (2019)

PSC, AIH and overlap syndrome in inflammatory bowel disease.
著者:: Trivedi, P, 等
出版事項: (2012)

Clinical Activity and Quality of Life Indices Are Valid Across Ulcerative Colitis But Not Crohn’s Disease Phenotypes
著者:: Taleban, Sasha, 等
出版事項: (2017)

Deposition of complement C9 in primary sclerosing cholangitis (PSC).
著者:: Shanahan, J, 等
出版事項: (1998)

ADHESION MOLECULE EXPRESSION IN PRIMARY SCLEROSING CHOLANGITIS (PSC)
著者:: Bloom, S, 等
出版事項: (1992)

Is Crohn's disease a rightly used eponym?
著者:: Van Hootegem, P, 等
出版事項: (2019)

Smoking status in therapeutic trials in Crohn's disease.
著者:: McGovern, D, 等
出版事項: (2005)

Sweet's syndrome: an unusual cutaneous feature of Crohn's disease or ulcerative colitis. The South West Gastroenterology Group.
著者:: Travis, S, 等
出版事項: (1997)

Primary sclerosing cholangitis: what is the role of ursodeoxycholic acid in therapy for PSC?
著者:: Chapman, R
出版事項: (2010)

TISSUE DISTRIBUTION OF AN AUTOANTIGEN SPECIFIC FOR PRIMARY SCLEROSING CHOLANGITIS (PSC)
著者:: Lo, S, 等
出版事項: (1992)

Inherited determinants of Crohn's disease and ulcerative colitis phenotypes: a genetic association study
著者:: Cleynen, I, 等
出版事項: (2015)

Genome analysis of the platypus reveals unique signatures of evolution.
著者:: Warren, W, 等
出版事項: (2008)

Incidence and clinical significance of immunogenicity to infliximab in Crohn's disease: a critical systematic review.
著者:: Cassinotti, A, 等
出版事項: (2009)

Review article: insurance risks for patients with ulcerative colitis or Crohn's disease.
著者:: Travis, S
出版事項: (1997)

Genotype-phenotype analysis of the Crohn's disease susceptibility haplotype on chromosome 5q31.
著者:: Armuzzi, A, 等
出版事項: (2003)

CRISPR/Cas9-mediated engineering of subtype-specific cell lines for iPSC-derived cardiomyocyte phenotyping
著者:: Sontayananon, N
出版事項: (2022)

The Crohn's disease–ulcerative colitis clinical appraisal update: emerging trends in clinical practice
著者:: Sandborn, W, 等
出版事項: (2016)

Combining clinical risk factors and genotype to predict postoperative recurrence of Crohn's disease
著者:: Johns, E, 等
出版事項: (2003)

NOD2 (CARD15), the first susceptibility gene for Crohn's disease.
著者:: McGovern, D, 等
出版事項: (2001)

Tumor-derived lactic acid generates a unique macrophage phenotype.
著者:: Suhartono, Timotius Marvin.
出版事項: (2010)

Unique sums and differences in finite Abelian groups
著者:: Leung, Ka Hin, 等
出版事項: (2022)